Evidence map›Paper›PMID 39905406›Full record

ArticleMicrobial cell factories2025

Antimicrobial and antiproliferative activity of biosynthesized manganese nanocomposite with amide derivative originated by endophytic Aspergillus terreus.

Nashwa El-Gazzar, Reem Farouk, Nervana S Diab, Gamal Rabie, Basel Sitohy

Erratum issuedAbstract read
In one paragraph

Article in Microbial cell factories, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Molecular characterization of ESBL-producingFrontiers in cellular and infection microbiology · 2026
    Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Nashwa El-GazzarDepartment of Botany and Microbiology, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt. ns_elgsazzar@zu.edu.eg.
Reem FaroukDepartment of Botany and Microbiology, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt.
Nervana S DiabDepartment of Biochemistry, Children Hospital, Faculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.
Gamal RabieDepartment of Botany and Microbiology, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt.
Basel SitohyDepartment of Clinical Microbiology, Infection and Immunology, Umeå University, 90185, Umeå, Sweden. basel.sitohy@umu.se.

Funding

Kempestiftelserna JCK22-0003
6 · The paper itself

Abstract

backgroundScientists have faced difficulties in synthesizing natural substances with potent biological activity from cost-effective sources. Endophytic fungi metabolites with nanoparticles have been utilized to develop a friendly, suitable procedure to address this problem and ameliorate the average amount of antioxidant, antimicrobial, and anticancer materials. Therefore, this study utilized endophytic fungi as a source of the natural extract with biosynthesized manganese nanoparticles (MnNPs) in the form of nanocomposites.

methodsThirty endophytic fungi were isolated and were assessed for their antioxidant activity by 1, 1-Diphenyl-2-picrylhydrazyl (DPPH) and antimicrobial activity. The most potent isolate was identified utilizing 18S rRNA and was applied to purify and separate their natural antimicrobial products by Flash column chromatography. In addition, the most potent product was identified based on instrumental analysis through Nuclear magnetic resonance (NMR), Fourier-transform infrared (FTIR), and Gas chromatography-mass spectrometry (GC.MS). The purified product was combined with biosynthsesized manganese nanoparticles (MnNPs) for the production of nanocomposite (MnNCs). Later on, the physicochemical features of MnNPs and its MnNCs were examined and then they were assessed for determination their biological activities.

resultsThe most potent isolate was identified as Aspergillus terreus with accession number OR243300. The antioxidant and antimicrobial product produced by the strain A. terreus was identified as an amide derivative consisting of 3-(2-Hydroxy-4,4-dimethyl-6-oxo-1-cyclohexen-1-yl)-4-oxopentanoic acid (HDOCOX) with the chemical formula C

conclusionThe use of HDOCOX, either alone or in combination with MnNPs, is a potential candidate for inhibiting pathogenic microbes and the development of an anticancer drug pipeline.

Indexed as

AmidesAnti-Infective AgentsAntineoplastic AgentsAspergillusManganeseNanocompositesAntioxidantsCell Line, TumorCell ProliferationEndophytesHumansMetal NanoparticlesMicrobial Sensitivity TestsAmidesAnti-Infective AgentsAntineoplastic AgentsAntioxidantsManganese3-(2-Hydroxy-4,4-dimethyl-6-oxo-1-cyclohexen-1-yl)-4-oxopentanoic acidAnticancer activityAntimicrobial activityAspergillus terreusManganese nanoparticlesNanocompositesNatural antimicrobial products

Identifiers

PMID39905406
PMCPMC11796263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.